Stay updated on Alvelestat in alpha1-antitrypsin COPD: Clinical Trial
Sign up to get notified when there's something new on the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page.

Latest updates to the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page
- ChecktodayChange DetectedRevision updated from v3.5.4 to v3.5.5, signaling a minor site/template revision. No content related to the study details, criteria, or results appears to be affected.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe page displays Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a new build version of the site.SummaryDifference0.0%

- Check43 days agoChange DetectedThis update reflects a change to the ClinicalTrials.gov page/version revision label (from v3.5.0 to v3.5.3), indicating a site release rather than a change to the study record itself.SummaryDifference0.1%

- Check72 days agoChange DetectedUpdated the terminology to 'Alpha-1-antitrypsin deficiency' to ensure consistent hyphenation with 'Alpha-1' across the page.SummaryDifference0.0%

- Check79 days agoChange DetectedSite revision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check93 days agoChange DetectedSite version updated from v3.4.2 to v3.4.3; no visible changes to study details or page content.SummaryDifference0.0%

Stay in the know with updates to Alvelestat in alpha1-antitrypsin COPD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page.